242 related articles for article (PubMed ID: 16738800)
1. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies.
Harro J
Amino Acids; 2006 Oct; 31(3):215-30. PubMed ID: 16738800
[TBL] [Abstract][Full Text] [Related]
2. The NPY system in stress, anxiety and depression.
Heilig M
Neuropeptides; 2004 Aug; 38(4):213-24. PubMed ID: 15337373
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
6. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
7. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
9. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
11. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Dhillon SS; Gingerich S; Belsham DD
Regul Pept; 2009 Aug; 156(1-3):96-103. PubMed ID: 19371763
[TBL] [Abstract][Full Text] [Related]
13. Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms.
Gao J; Ghibaudi L; Hwa JJ
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E706-11. PubMed ID: 15187000
[TBL] [Abstract][Full Text] [Related]
14. Molecular evolution of NPY receptor subtypes.
Larhammar D; Salaneck E
Neuropeptides; 2004 Aug; 38(4):141-51. PubMed ID: 15337367
[TBL] [Abstract][Full Text] [Related]
15. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
[TBL] [Abstract][Full Text] [Related]
16. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
17. Central functions of neuropeptide Y in mood and anxiety disorders.
Wu G; Feder A; Wegener G; Bailey C; Saxena S; Charney D; Mathé AA
Expert Opin Ther Targets; 2011 Nov; 15(11):1317-31. PubMed ID: 21995655
[TBL] [Abstract][Full Text] [Related]
18. Research in anxiety disorders: from the bench to the bedside.
Garner M; Möhler H; Stein DJ; Mueggler T; Baldwin DS
Eur Neuropsychopharmacol; 2009 Jun; 19(6):381-90. PubMed ID: 19327970
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
20. Interactions between NPY and CRF in the amygdala to regulate emotionality.
Sajdyk TJ; Shekhar A; Gehlert DR
Neuropeptides; 2004 Aug; 38(4):225-34. PubMed ID: 15337374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]